BACKGROUND: Multimodal protocols may enhance postoperative recovery. The aim of this study was to evaluate the influence of a multimodal protocol in the clinical results, insulin resistance, and inflammatory response to trauma in morbidly obese patients undergoingsleeve gastrectomy. METHODS: The population of the study consisted of morbidly obese patients, who were operated using sleeve gastrectomy, from Cuiaba, MT, Brazil, between April and October 2012. Twenty patients were divided into two groups whom received either traditional preoperative care or treatment following the Acerto (accelerating the total recovery of patients in the postoperative period) protocol. The study examined inflammatory response and insulin resistance by measuring levels of glucose, insulin, Homa-IR, reactive C protein, albumin, prealbumin, alpha 1 acid glycoprotein, interleukin 6, and glycosylated hemoglobin. In addition, the study investigated hydration levels, nausea and vomiting, hypertension, and length of hospital stay. RESULTS: Patients who followed the Acerto protocol showed no postoperative hypertensive crises (p = 0.03), and 30 % less vomiting (p = 0.35), and showed significant reductions in length of hospital stay, on average of 3 days versus 2 days (p = 0.02). There were not significant statistical differences between the two groups with respect to inflammatory response and insulin resistance (p > 0.05). CONCLUSION: This pilot study suggests that the prescription of the Acerto multimodal protocol for morbidly obese patients undergoingsleeve gastrectomy was safe, reduced the rate hypertensive complications, and the length of both ICU and hospital postoperative stay. However, there was no improvement in postoperative insulin resistance or inflammatory acute phase response.
RCT Entities:
BACKGROUND: Multimodal protocols may enhance postoperative recovery. The aim of this study was to evaluate the influence of a multimodal protocol in the clinical results, insulin resistance, and inflammatory response to trauma in morbidly obesepatients undergoing sleeve gastrectomy. METHODS: The population of the study consisted of morbidly obesepatients, who were operated using sleeve gastrectomy, from Cuiaba, MT, Brazil, between April and October 2012. Twenty patients were divided into two groups whom received either traditional preoperative care or treatment following the Acerto (accelerating the total recovery of patients in the postoperative period) protocol. The study examined inflammatory response and insulin resistance by measuring levels of glucose, insulin, Homa-IR, reactive C protein, albumin, prealbumin, alpha 1 acid glycoprotein, interleukin 6, and glycosylated hemoglobin. In addition, the study investigated hydration levels, nausea and vomiting, hypertension, and length of hospital stay. RESULTS:Patients who followed the Acerto protocol showed no postoperative hypertensive crises (p = 0.03), and 30 % less vomiting (p = 0.35), and showed significant reductions in length of hospital stay, on average of 3 days versus 2 days (p = 0.02). There were not significant statistical differences between the two groups with respect to inflammatory response and insulin resistance (p > 0.05). CONCLUSION: This pilot study suggests that the prescription of the Acerto multimodal protocol for morbidly obesepatients undergoing sleeve gastrectomy was safe, reduced the rate hypertensive complications, and the length of both ICU and hospital postoperative stay. However, there was no improvement in postoperative insulin resistance or inflammatory acute phase response.
Authors: K C H Fearon; O Ljungqvist; M Von Meyenfeldt; A Revhaug; C H C Dejong; K Lassen; J Nygren; J Hausel; M Soop; J Andersen; H Kehlet Journal: Clin Nutr Date: 2005-04-21 Impact factor: 7.324
Authors: Arman Kahokehr; Tarik Sammour; Kamran Zargar-Shoshtari; Lisa Thompson; Andrew G Hill Journal: Int J Surg Date: 2008-12-03 Impact factor: 6.071
Authors: U O Gustafsson; M J Scott; W Schwenk; N Demartines; D Roulin; N Francis; C E McNaught; J Macfie; A S Liberman; M Soop; A Hill; R H Kennedy; D N Lobo; K Fearon; O Ljungqvist Journal: World J Surg Date: 2013-02 Impact factor: 3.352
Authors: Alberto Bicudo-Salomão; Márcio Bertocco Meireles; Cervantes Caporossi; Pedro Luis Reis Crotti; José Eduardo de Aguilar-Nascimento Journal: Rev Col Bras Cir Date: 2011 Jan-Feb
Authors: Ola S Ahmed; Ailín C Rogers; Jarlath C Bolger; Achille Mastrosimone; William B Robb Journal: J Gastrointest Surg Date: 2018-02-27 Impact factor: 3.452
Authors: Richard S Hoehn; Aaron P Seitz; Kathleen E Singer; Jonathan R Thompson; Brad M Watkins Journal: J Gastrointest Surg Date: 2019-01-28 Impact factor: 3.452
Authors: Richard L Seip; Samantha Lee; Tara McLaughlin; Ilene Staff; Aloys Nsereko; Stephen Thompson; Connie Santana; Darren S Tishler; Pavlos Papasavas Journal: World J Surg Date: 2021-10-19 Impact factor: 3.352
Authors: Piotr Małczak; Magdalena Pisarska; Major Piotr; Michał Wysocki; Andrzej Budzyński; Michał Pędziwiatr Journal: Obes Surg Date: 2017-01 Impact factor: 4.129
Authors: Piotr Małczak; Magdalena Pisarska; Michał Wysocki; Piotr Major; Michał Pędziwiatr Journal: J Gastrointest Surg Date: 2018-05-31 Impact factor: 3.452
Authors: Erik Stenberg; Luiz Fernando Dos Reis Falcão; Mary O'Kane; Ronald Liem; Dimitri J Pournaras; Paulina Salminen; Richard D Urman; Anupama Wadhwa; Ulf O Gustafsson; Anders Thorell Journal: World J Surg Date: 2022-01-04 Impact factor: 3.352